This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
City of London will be hosting its annual Wealth Management awards next month.
We hope your experience with Accendo Markets over the past 12 months warrants a vote in the following category; “BEST EXECUTION ONLY CFD PROVIDER”
_____________________________________________________________________________
Babcock International | JP Morgan ups TP to 1230p from 1120p, overweight |
Bovis Homes | UBS ups TP to 700p from 560p, neutral |
BP | Deutsche Bank ups TP to 520p from 500p |
British American Tobacco | Investec ups TP to 3800p from 3350p, Buy |
Capita | Investec ups TP to 865p from 630p, sell |
Capita | Westhouse ups TP to 755p from 661p, sell |
Carillion | UBS cuts TP to 230p from 240p, sell |
Dixons Retail | Deutsche Bank ups TP to 36p from 31p, Buy |
GlaxoSmithKline | Deutsche Bank ups TP to 1,530p from 1,440p |
Hammerson | UBS ups TP to 560p from 525p, Buy |
Hunting | HSBC ups TP to 1050p from 1020p, overweight |
ICAP | UBS downgrades to sell from neutral; TP to 305p from 330p |
IMI | UBS ups TP to 1100p from 1000p, sell |
Inmarsat | HSBC ups TP to 720p from 650p, neutral |
Perform Group | JP Morgan ups TP to 541p from 416p, neutral |
Playtech | Deutsche Bank ups TP to 650p from 550p |
Schroders | Credit Suisse ups TP to 2,150p from 1,800p, neutral |
Serco Group | Investec ups TP to 550p from 500p, sell |
SThree | HSBC downgrades to neutral from overweight |
Tullett Prebon | UBS downgrades to sell from neutral; ups TP to 250p from 244p |
Wolseley | UBS ups TP to 3375p from 2800p, neutral |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research